Ha habido 50 transacciones internas recientes registradas para Arcus Biosciences, Inc. (RCUS), incluyendo 17 compras y 31 ventas. El total de compras internas fue valorado en $32.3M y el total de ventas internas en $6.53M.
Internos destacados con actividad reciente incluyen Rosen Terry J, Jaen Juan C., Goeltz Ii Robert C.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RCUS
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-23 |
Rosen Terry J |
Chief Executive Officer |
Concesión de RSU |
315,000 |
$22.13 |
$6.97M |
315,000 |
| 2026-01-23 |
Jaen Juan C. |
President |
Concesión de RSU |
126,000 |
$22.13 |
$2.79M |
126,000 |
| 2026-01-23 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Concesión de RSU |
24,000 |
- |
- |
91,924 |
| 2026-01-23 |
Jarrett Jennifer |
Chief Operating Officer |
Concesión de RSU |
126,000 |
$22.13 |
$2.79M |
126,000 |
| 2026-01-23 |
Azoy Alexander |
Chief Accounting Officer |
Concesión de RSU |
14,050 |
$22.13 |
$310.93K |
14,050 |
| 2026-01-23 |
Tang Carolyn C. |
General Counsel |
Concesión de RSU |
96,000 |
$22.13 |
$2.12M |
96,000 |
| 2026-01-23 |
Markus Richard |
Chief Medical Officer |
Concesión de RSU |
24,000 |
- |
- |
89,647 |
| 2026-01-08 |
Rosen Terry J |
Chief Executive Officer |
Donación (Otorgada) |
35,000 |
- |
- |
2,157,409 |
| 2026-01-05 |
Jaen Juan C. |
President |
Venta Informativa |
100 |
$23.20 |
$2.32K |
922,240 |
| 2025-12-31 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Venta Informativa |
6,552 |
$23.38 |
$153.19K |
67,924 |
| 2025-12-30 |
Rosen Terry J |
Chief Executive Officer |
Donación (Otorgada) |
2,400 |
- |
- |
2,192,409 |
| 2025-12-18 |
Azoy Alexander |
Chief Accounting Officer |
Venta Informativa |
4,343 |
$22.25 |
$96.61K |
18,531 |
| 2025-12-17 |
Rosen Terry J |
Chief Executive Officer |
Venta Informativa |
25,744 |
$22.16 |
$570.47K |
2,194,809 |
| 2025-12-17 |
Jaen Juan C. |
President |
Venta Informativa |
9,983 |
$22.16 |
$221.22K |
346,012 |
| 2025-12-17 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Venta Informativa |
5,960 |
$22.16 |
$132.07K |
74,476 |
| 2025-12-17 |
Jarrett Jennifer |
Chief Operating Officer |
Venta Informativa |
9,983 |
$22.16 |
$221.22K |
193,024 |
| 2025-12-17 |
Azoy Alexander |
Chief Accounting Officer |
Venta Informativa |
2,113 |
$22.16 |
$46.82K |
22,874 |
| 2025-12-17 |
Tang Carolyn C. |
General Counsel |
Venta Informativa |
6,810 |
$22.16 |
$150.91K |
124,734 |
| 2025-12-17 |
Markus Richard |
Chief Medical Officer |
Venta Informativa |
4,494 |
$22.16 |
$99.58K |
65,647 |
| 2025-12-16 |
Rosen Terry J |
Chief Executive Officer |
Venta Informativa |
28,947 |
$21.88 |
$633.48K |
2,220,553 |
| 2025-12-16 |
Jaen Juan C. |
President |
Venta Informativa |
11,225 |
$21.88 |
$245.65K |
355,995 |
| 2025-12-16 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Venta Informativa |
6,702 |
$21.88 |
$146.67K |
80,436 |
| 2025-12-16 |
Jarrett Jennifer |
Chief Operating Officer |
Venta Informativa |
11,225 |
$21.88 |
$245.65K |
203,007 |
| 2025-12-16 |
Azoy Alexander |
Chief Accounting Officer |
Venta Informativa |
2,376 |
$21.88 |
$52K |
24,987 |
| 2025-12-16 |
Tang Carolyn C. |
General Counsel |
Venta Informativa |
7,658 |
$21.88 |
$167.59K |
131,544 |
| 2025-12-16 |
Markus Richard |
Chief Medical Officer |
Venta Informativa |
5,052 |
$21.88 |
$110.56K |
70,141 |
| 2025-12-04 |
Jaen Juan C. |
President |
Venta Informativa |
82,997 |
$24.71 |
$2.05M |
954,063 |
| 2025-11-26 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Venta Informativa |
5,000 |
$25.00 |
$125K |
87,138 |
| 2025-11-26 |
Azoy Alexander |
Chief Accounting Officer |
Ejercicio de Opciones (Venta) |
1,900 |
$13.33 |
$25.33K |
9,500 |
| 2025-11-18 |
Jaen Juan C. |
President |
Venta Informativa |
5,050 |
$19.75 |
$99.74K |
1,037,060 |
| 2025-11-17 |
Jaen Juan C. |
President |
Venta Informativa |
7,836 |
$20.71 |
$162.31K |
1,042,110 |
| 2025-11-07 |
Jarrett Jennifer |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
50,291 |
$1.23 |
$61.74K |
80,583 |
| 2025-10-30 |
Jaen Juan C. |
President |
Venta Informativa |
4,314 |
$20.32 |
$87.65K |
1,087,060 |
| 2025-10-29 |
Jaen Juan C. |
President |
Venta Informativa |
800 |
$22.04 |
$17.64K |
1,091,374 |
| 2025-10-28 |
Goeltz Ii Robert C. |
Chief Financial Officer |
Venta Informativa |
5,000 |
$20.00 |
$100K |
92,138 |
| 2025-10-28 |
Jaen Juan C. |
President |
Venta Informativa |
19,019 |
$20.19 |
$383.94K |
1,169,214 |
| 2025-10-08 |
Jarrett Jennifer |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
37,792 |
$1.23 |
$46.39K |
130,874 |
| 2025-10-06 |
Jarrett Jennifer |
Chief Operating Officer |
Ejercicio de Opciones (Venta) |
12,500 |
$1.23 |
$15.35K |
168,666 |
| 2025-09-29 |
Azoy Alexander |
Chief Accounting Officer |
Venta Informativa |
2,831 |
$13.00 |
$36.8K |
27,363 |
| 2025-09-05 |
Azoy Alexander |
Chief Accounting Officer |
Venta Informativa |
1,579 |
$11.88 |
$18.76K |
30,194 |
| 2025-06-10 |
Perlman Andrew J |
Director |
Concesión de RSU |
38,300 |
$10.02 |
$383.77K |
38,300 |
| 2025-06-10 |
Falberg Kathryn E |
Director |
Concesión de RSU |
38,300 |
$10.02 |
$383.77K |
38,300 |
| 2025-06-10 |
Kaneko Yasunori |
Director |
Concesión de RSU |
13,300 |
- |
- |
33,300 |
| 2025-06-10 |
Machado Patrick |
Director |
Concesión de RSU |
38,300 |
$10.02 |
$383.77K |
38,300 |
| 2025-06-10 |
Lacey David L. |
Director |
Concesión de RSU |
38,300 |
$10.02 |
$383.77K |
38,300 |
| 2025-06-10 |
Lambert Nicole |
Director |
Concesión de RSU |
13,300 |
- |
- |
37,300 |
| 2025-06-10 |
Ribas Antoni |
Director |
Concesión de RSU |
38,300 |
$10.02 |
$383.77K |
38,300 |
| 2025-02-27 |
Rosen Terry J |
Chief Executive Officer |
Compra Informativa |
19,800 |
$10.18 |
$201.47K |
2,554,160 |
| 2025-02-27 |
Kaneko Yasunori |
Director |
Compra Informativa |
20,000 |
$10.06 |
$201.2K |
28,400 |
| 2025-02-18 |
Gilead Sciences, Inc. |
10 Percent Owner |
Compra Informativa |
1,363,636 |
$11.00 |
$15M |
31,424,760 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
